Finding a very rare mutation in non-Caucasian LCAT patients from Southwest Asia for the first time.
J Cell Biochem
; 120(5): 7096-7100, 2019 May.
Article
de En
| MEDLINE
| ID: mdl-30506915
ABSTRACT
INTRODUCTION:
Lecithin cholesterol acyltransferase (LCAT) deficiency is an autosomal recessive disorder occurred by different mutations in the LCAT gene that cause two extremely rare syndromes including familial LCAT deficiency (FLD) and fish-eye disease (FED). Unlike FED in FLD renal failure is the most important defect due to deposition of abnormal lipoproteins in the renal stroma. In this study, FLD patients from the North of Iran were investigated for mutations in the LCAT gene. MATERIALS ANDMETHODS:
Eight patients with corneal opacification and renal defect were analyzed for mutations in the LCAT gene by PCR sequencing.RESULTS:
Sequencing analysis revealed a missense pathogenic variation c.301 G>A in exon 2 of LCAT gene in all patients changing the amino acid aspartate to asparagine at the conserved position of amino acid 101 of LCAT protein.CONCLUSION:
In this study, a very rare variation was reported for the first time in this part of the world. Investigation of a larger number of LCAT patients in different parts of Iran can provide availability of mutations panel that is useful for phenotype prediction and also prenatal diagnosis programming in families with a previous history of the disease.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Diagnostic_studies
/
Prognostic_studies
Langue:
En
Journal:
J Cell Biochem
Année:
2019
Type de document:
Article
Pays d'affiliation:
Iran